Bristol-Myers Squibb Co (BMY)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Giovanni Caforio
Employees:
34,300
345 PARK AVE, NEW YORK, NY 10154
2125464000

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple myeloma.

Data derived from most recent annual or quarterly report
Market Cap 109.203 Billion Shares Outstanding2.18 Billion Avg 30-day Volume 13.865 Million
P/E Ratio14.488 Dividend Yield3.916 EPS0.75
Price to Revenue2.6713 Debt to Equity1.2939 EBITDA18.442 Billion
Price to Book Value4.1394 Operating Margin16.9601 Enterprise Value150.016 Billion
Current Ratio1.178 EPS Growth0.283 Quick Ratio0.767
1 Yr BETA 0.408 52-week High/Low 78.62 / 48.25 Profit Margin18.4778
Operating Cash Flow Growth-6.5354 Free Cash Flow to Firm (FCFF) TTM 11.485 Billion Free Cash Flow to Equity (FCFE) TTM6.637 Billion
Altman Z-Score2.4498
Earnings Report2024-02-02
View SEC Filings from BMY instead.

View recent insider trading info

Bristol-Myers Squibb Co YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding BMY (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding BMY

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

  • 4: filed on 2023-11-30 by BOERNER CHRISTOPHER S.
  • 4: filed on 2023-11-24 by LEUNG SANDRA
  • 4: filed on 2023-11-21 by SAMUELS THEODORE R. II
  • 4: filed on 2023-11-03 by BOERNER CHRISTOPHER S.
  • 4: filed on 2023-10-12 by CAFORIO GIOVANNI
  • 4: filed on 2023-10-04 by GALLMAN CARI
  • 3: filed on 2023-10-04 by GALLMAN CARI
  • 4: filed on 2023-10-03 by YALE PHYLLIS R
  • 4: filed on 2023-10-03 by STORCH GERALD L
  • 4: filed on 2023-10-03 by SAMUELS THEODORE R. II

    • Events (8k)

  • 8-K: filed on 2023-11-13:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K/A: filed on 2023-10-31:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2023-10-26:
    Item 2.02: Results of Operations and Financial Condition
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-08-10:
    Item 8.01: Other Events
  • 8-K: filed on 2023-07-27:
    Item 2.02: Results of Operations and Financial Condition
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-05-04:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 5.07: Submission of Matters to a Vote of Security Holders
  • 8-K: filed on 2023-04-27:
    Item 2.02: Results of Operations and Financial Condition
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-04-26:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-02-28:
    Item 8.01: Other Events
  • 8-K: filed on 2023-02-02:
    Item 2.02: Results of Operations and Financial Condition
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits

    • Proposed Sales (Form 144)

  • 144: filed on 2023-05-03:
  • 144: filed on 2023-08-03:
  • 144: filed on 2023-08-24:

    • Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    11.6 Thousand total shares from 2 transactions

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    BOERNER CHRISTOPHER S. CHIEF EXECUTIVE OFFICER

    • Officer
    		 79,384 2023-11-28 3

    LEUNG SANDRA EVP, GENERAL COUNSEL

    • Officer
    		 432,046 2023-11-21 2

    SAMUELS THEODORE R. II

    • Director
    		 35,500 2023-11-20 6

    CAFORIO GIOVANNI BOARD CHAIR AND CEO

    • Officer
    • Director
    		 367,495 2023-10-10 3

    GALLMAN CARI EVP, CORPORATE AFFAIRS

    • Officer
    		 206 2023-10-02 2

    STORCH GERALD L

    • Director
    		 0 2023-09-30 5

    YALE PHYLLIS R

    • Director
    		 0 2023-09-30 5

    ARDUINI PETER J

    • Director
    		 0 2023-09-30 5

    RICE DERICA W

    • Director
    		 0 2023-09-30 5

    HALLER JULIA A

    • Director
    		 0 2023-09-30 5

    BHATT DEEPAK

    • Director
    		 0 2023-09-30 5

    POWELL ANN EVP, CHIEF HUMAN RESOURCES

    • Officer
    		 27,868 2023-08-24 3

    PLENGE ROBERT M EVP, CHIEF RESEARCH OFFICER

    • Officer
    		 6,784 2023-08-03 2

    HIRAWAT SAMIT EVP,CHIEF MED.OFFR.,DRUG DEV.

    • Officer
    		 47,245 2023-07-01 2

    WEESE MICHELLE EVP, CORPORATE AFFAIRS

    • Officer
    		 3,453 2023-07-01 2

    LENKOWSKY ADAM EVP, CHIEF COMMERCIAL OFFICER

    • Officer
    		 10,574 2023-06-03 3

    VESSEY RUPERT EVP & PRESIDENT, RESEARCH

    • Officer
    		 48,407 2023-05-03 2

    GREENLEES SHARON SVP & CONTROLLER

    • Officer
    		 609 2023-05-02 2

    MILY ELIZABETH EVP, STRATEGY & BD

    • Officer
    		 34,734 2023-04-01 2

    SHANAHAN KARIN EVP, GLOB. PROD. DEV. & SUPPLY

    • Officer
    		 3,974 2023-04-01 2

    ELKINS DAVID V EVP, CHIEF FINANCIAL OFFICER

    • Officer
    		 163,757 2023-03-10 1

    MEYERS GREGORY SCOTT EVP, CHIEF DIGITAL & TECH OFF.

    • Officer
    		 3,497 2023-03-10 2

    PRICE PAULA A

    • Director
    		 0 2023-02-01 1

    VOUSDEN KAREN H

    • Director
    		 0 2023-02-01 1

    HIDALGO MEDINA MANUEL

    • Director
    		 0 2023-02-01 2

    SANTIAGO KAREN MURPHY SVP & CONTROLLER

    • Officer
    		 16,704 2022-03-14 0

    VON AUTENRIED PAUL EVP, CHIEF INFORMATION OFFICER

    • Officer
    		 63,536 2021-11-22 0

    DUBOW ADAM SVP,CHIEFCOMPLIANCE&ETHICSOFF.

    • Officer
    		 14,749 2021-07-30 0

    BONNEY MICHAEL W

    • Director
    		 9,342 2021-06-30 0

    EID JOSEPH SVP,HEAD GLOB. MEDICAL AFFAIRS

    • Officer
    		 13,794 2021-06-03 0

    SCHMUKLER LOUIS S EVP,PRES.,GLOB.PROD. & SUPPLY

    • Officer
    		 31,956 2021-05-10 0

    BERTOLINI ROBERT J

    • Director
    		 26,648 2021-03-31 0

    EMMENS MATTHEW

    • Director
    		 26,999 2021-03-31 0

    PALIWAL DINESH C

    • Director
    		 40,501 2021-03-31 0

    SATO VICKI L

    • Director
    		 0 2021-02-01 0

    AHMED NADIM EVP AND PRESIDENT, HEMATOLOGY

    • Officer
    		 40,855 2020-12-31 0

    LACY ALAN J

    • Director
    		 0 2020-06-30 0

    GROBSTEIN MICHAEL

    • Director
    		 0 2020-06-30 0

    BANCROFT CHARLES A EVP, HEAD OF INTEGRATION

    • Officer
    		 529,844 2020-03-10 0

    ELICKER JOHN E EVP, INVESTOR RELATIONS

    • Officer
    		 70,946 2020-03-10 0

    METCALFE KATHRYN EVP, CORPORATE AFFAIRS

    • Officer
    		 0 2020-03-10 0

    BIONDI PAUL SVP, HEAD OF STRATEGY & BD

    • Officer
    		 6,214 2019-10-02 0

    LYNCH THOMAS J. JR. EVP & CHIEF SCIENTIFIC OFFICER

    • Officer
    		 22,223 2019-04-03 0

    STORCH GERALD L

    STORCH GERALD L

    • Director
    		 0 2018-09-30 5

    BASELGA JOSE

    • Director
    		 No longer subject to file 2018-09-30 0

    GORDON MURDO EVP, CHIEF COMMERCIAL OFFICER

    • Officer
    		 No longer subject to file 2018-08-01 0

    CALDARELLA JOSEPH C SVP & CONTROLLER

    • Officer
    		 48,076 2017-09-06 0

    NIELSEN ANNE CHIEF COMPLIANCE & ETHICS OFF

    • Officer
    		 37,974 2017-09-03 0

    ANDREOTTI LAMBERTO

    • Director
    		 1,176,844 2017-04-06 0

    CUSS FRANCIS M EVP & CSO

    • Officer
    		 321,906 2017-03-10 0

    BLIN EMMANUEL SVP, CHIEF STRATEGY OFFICER

    • Officer
    		 20,138 2017-03-10 0

    WEST TOGO D JR

    • Director
    		 0 2017-02-01 0

    GLIMCHER LAURIE H M.D.

    • Director
    		 0 2017-02-01 0

    CAMPBELL LEWIS B

    • Director
    		 2,110 2016-03-08 0

    CORNELIUS JAMES M

    • Director
    		 79,851 2015-03-31 0

    MOED SAMUEL J SVP, STRAT PLAN & ANALYSIS

    • Officer
    		 31,615 2015-03-13 0

    DANIELS BRIAN SVP GLOBAL DEV & MED AFFAIRS

    • Officer
    		 No longer subject to file 2014-07-01 0

    HELLER FRANCES K SVP, BUSINESS DEVELOPMENT

    • Officer
    		 4,218 2014-03-10 0

    SIGAL ELLIOT EVP, CSO & PRESIDENT R&D

    • Officer
    • Director
    		 195,300 2013-06-03 0

    CAZALA BEATRICE J EVP COMMERCIAL OPERATIONS

    • Officer
    		 177,118 2013-05-31 0

    FREEH LOUIS J

    • Director
    		 0 2013-02-01 0

    WILLIAMS R SANDERS

    • Director
    		 0 2013-02-01 0

    CELENTANO JOHN E SVP HR PUBLIC AFFAIRS & PHILAN

    • Officer
    		 142,142 2012-03-06 0

    LEVIN JEREMY M SVP STRAT TRANSACTIONS

    • Officer
    		 43,689 2011-10-01 0

    CARLO DE NOTARISTEFANI PRES TECH OPS & SUPP FNCTNS

    • Officer
    		 8,432 2011-06-14 0

    HOOPER ANTHONY C SVP COMOPS PRES USJAP INT

    • Officer
    		 208,419 2011-05-13 0

    JOHANSSON LEIF

    • Director
    		 0 2011-02-01 0

    ZITO ROBERT T SVP & CHIEF COMM OFFICER

    • Officer
    		 35,469 2010-03-06 0

    MCBRIDE ANTHONY A SVP HUMAN RESOURCES

    • Officer
    		 34,292 2010-03-06 0

    HUET JEAN-MARC EVP & CFO

    • Officer
    		 25,000 2009-04-30 0

    ROBINSON JAMES D III

    • Director
    		 0 2007-12-31 0

    BONFIELD ANDREW R J EVP & CFO

    • Officer
    		 150,206 2007-10-01 0

    BEAR STEPHEN E SVP, HUMAN RESOURCES

    • Officer
    		 76,257 2007-09-10 0

    COFFMAN VANCE D

    • Director
    		 44,870 2006-09-29 0

    DOLAN PETER R FORMER CEO

    • Officer
    • Director
    		 606,946 2006-09-08 0

    BODNAR ANDREW G SVP, STRAT & MED & EXT AFFAIRS

    • Officer
    		 323,464 2006-09-08 0

    ALLEN ROBERT E

    • Director
    		 2,500 2006-05-02 0

    GLIMCHER LAURIE H MD

    • Director
    		 2,500 2006-05-02 0

    SULLIVAN LOUIS W

    • Director
    		 22,932 2006-03-31 0

    GERSTNER LOUIS V JR

    • Director
    		 42,402 2006-03-09 0

    MCGOLDRICK JOHN L EXECUTIVE VP

    • Officer
    		 223,999 2006-03-07 0

    DIXON WENDY L CMO & PRES, GLOBAL MARKETING

    • Officer
    		 128,868 2006-03-07 0

    HOWSON TAMAR D SVP, CORP & BUS DEVELOPMENT

    • Officer
    		 112,671 2006-03-07 0

    WILLARD RICHARD K SVP & GENERAL COUNSEL

    • Officer
    		 203,300 2006-03-07 0

    ZABOR DAVID L VP STRAT BUS INITIATIVES

    • Officer
    		 104,665 2006-03-07 0

    DWYER EDWARD M VICE PRESIDENT & TREASURER

    • Officer
    		 41,257 2006-03-07 0

    WOLGEMUTH RICHARD L SVP, GLOBAL REG SCIENCES

    • Officer
    		 68,936 2006-03-07 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed    		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

    BOERNER CHRISTOPHER S. - Officer CHIEF EXECUTIVE OFFICER

    		2023-11-30 18:32:01 -0500 2023-11-28 P 3,071 $48.86 a 79,384 direct

    LEUNG SANDRA - Officer EVP, GENERAL COUNSEL trust (slat)

    		2023-11-24 14:38:18 -0500 2023-11-21 J 9,830 $48.75 a 93,436 indirect -1.4871 0.6833 0.6833 6 -2.09 4

    LEUNG SANDRA - Officer EVP, GENERAL COUNSEL

    		2023-11-24 14:38:18 -0500 2023-11-21 J 9,830 $48.75 d 331,414 direct -1.4871 0.6833 0.6833 6 -2.09 4

    SAMUELS THEODORE R. II - Director

    		2023-11-21 19:01:13 -0500 2023-11-20 P 8,500 $49.81 a 35,500 direct 0.688 -0.0809 0.688 2 -1.4164 5

    BOERNER CHRISTOPHER S. - Officer CHIEF EXECUTIVE OFFICER

    		2023-11-03 18:30:28 -0400 2023-11-01 A 11,858 a 11,858 direct

    BOERNER CHRISTOPHER S. - Officer CHIEF EXECUTIVE OFFICER

    		2023-11-03 18:30:28 -0400 2023-11-01 A 17,788 a 17,788 direct

    CAFORIO GIOVANNI - Director - Officer BOARD CHAIR AND CEO

    		2023-10-12 19:13:05 -0400 2023-10-10 G 440 d 367,495 direct 1.2396 -0.0177 -13.1928 1.5938 3 -14.1491 28

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    BRISTOL-MYERS SQUIBB CO BMY 2023-12-04 14:45:03 UTC 5.07 0.25 0
    BRISTOL-MYERS SQUIBB CO BMY 2023-12-04 14:15:04 UTC 5.07 0.25 0
    BRISTOL-MYERS SQUIBB CO BMY 2023-12-04 13:45:03 UTC 5.07 0.25 0
    BRISTOL-MYERS SQUIBB CO BMY 2023-12-04 13:15:04 UTC 5.07 0.25 0
    BRISTOL-MYERS SQUIBB CO BMY 2023-12-04 12:45:04 UTC 5.07 0.25 0
    BRISTOL-MYERS SQUIBB CO BMY 2023-12-01 22:15:04 UTC 5.07 0.25 0
    BRISTOL-MYERS SQUIBB CO BMY 2023-12-01 21:45:05 UTC 5.07 0.25 0
    BRISTOL-MYERS SQUIBB CO BMY 2023-12-01 21:15:04 UTC 5.07 0.25 0
    BRISTOL-MYERS SQUIBB CO BMY 2023-12-01 20:45:04 UTC 5.07 0.25 0
    BRISTOL-MYERS SQUIBB CO BMY 2023-12-01 20:15:04 UTC 5.07 0.25 0
    BRISTOL-MYERS SQUIBB CO BMY 2023-12-01 19:45:04 UTC 5.07 0.25 0
    BRISTOL-MYERS SQUIBB CO BMY 2023-12-01 19:15:04 UTC 5.07 0.25 0
    BRISTOL-MYERS SQUIBB CO BMY 2023-12-01 18:45:05 UTC 5.07 0.25 0
    BRISTOL-MYERS SQUIBB CO BMY 2023-12-01 18:15:03 UTC 5.07 0.25 0
    BRISTOL-MYERS SQUIBB CO BMY 2023-12-01 17:45:04 UTC 5.07 0.25 0
    BRISTOL-MYERS SQUIBB CO BMY 2023-12-01 17:15:03 UTC 5.07 0.25 0
    BRISTOL-MYERS SQUIBB CO BMY 2023-12-01 16:45:03 UTC 5.07 0.25 0
    BRISTOL-MYERS SQUIBB CO BMY 2023-12-01 16:15:04 UTC 5.07 0.25 0
    BRISTOL-MYERS SQUIBB CO BMY 2023-12-01 15:45:03 UTC 5.07 0.25 0
    BRISTOL-MYERS SQUIBB CO BMY 2023-12-01 15:15:05 UTC 5.07 0.25 0

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin
    FundVantage Trust- Gotham Master Neutral Fund BMY -13.0 shares, $-783.77 2020-09-30 N-PORT
    FundVantage Trust- Gotham Neutral 500 Fund BMY -42.0 shares, $-2651.46 2021-03-31 N-PORT
    American Century Capital Portfolios, Inc.- AC Alternatives Market Neutral Value Fund BMY -5384.0 shares, $-318571.28 2021-09-30 N-PORT
    Weiss Strategic Interval Fund- Weiss Strategic Interval Fund BMY -13266.0 shares, $-943079.94 2022-09-30 N-PORT
    Waycross Independent Trust- WAYCROSS LONG/SHORT EQUITY FUND BMY -16300.0 shares, $-1004895.0 2023-08-31 N-PORT
    Advantage Advisers Xanthus Fund, L.L.C.- Advantage Advisers Xanthus Fund, L.L.C. BMY -106284.0 shares, $-6168723.36 2023-09-30 N-PORT
    INVESTMENT MANAGERS SERIES TRUST II- AXS Market Neutral Fund BMY -1853.0 shares, $-107548.12 2023-09-30 N-PORT
    Tidal Trust II- Blueprint Chesapeake Multi-Asset Trend ETF BMY -3623.0 shares, $-210278.92 2023-09-30 N-PORT

    Congressional Transactions Past 6-Months

    To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***
    Congress Person Party Chamber Filing Filing Date Transaction Date Security Type Owner Transaction Amount
    senator Thomas H Tuberville republican Senate Filing 2023-11-16 2023-10-17 JT P $1,001-$15,000
    Hon. Greg Stanton House Filing 2023-10-26 2023-10-24 SP S $1,001-$15,000
    Hon. Greg Stanton House Filing 2023-10-21 2023-09-26 SP P $1,001-$15,000
    senator Daniel S Sullivan republican Senate Filing 2023-09-22 2023-08-22 JT S $1,001-$15,000
    senator Daniel S Sullivan republican Senate Filing 2023-09-18 2023-08-22 JT S $1,001-$15,000
    Hon. Daniel Goldman House Filing 2023-08-08 2023-07-12 S $15,001-$50,000
    senator Shelley M Capito republican Senate Filing 2023-06-14 2023-05-10 SP S $1,001-$15,000
    WhaleWisdom Logo

    Elevate your investments